|
Wijayatunge, Ranjula; Holmstrom, Sam R; Foley, Samantha B et al. (2018) Deficiency of the Endocytic Protein Hip1 Leads to Decreased Gdpd3 Expression, Low Phosphocholine, and Kypholordosis. Mol Cell Biol 38:
|
|
Mgbemena, Victoria E; Signer, Robert A J; Wijayatunge, Ranjula et al. (2017) Distinct Brca1 Mutations Differentially Reduce Hematopoietic Stem Cell Function. Cell Rep 18:947-960
|
|
Philips, S T; Hildenbrand, Z L; Oravecz-Wilson, K I et al. (2014) Toward a therapeutic reduction of imatinib refractory myeloproliferative neoplasm-initiating cells. Oncogene 33:5379-90
|
|
Ames, Heather M; Wang, Anmin A; Coughran, Alanna et al. (2013) Huntingtin-interacting protein 1 phosphorylation by receptor tyrosine kinases. Mol Cell Biol 33:3580-93
|
|
Soyombo, Abigail A; Wu, Yipin; Kolski, Lauren et al. (2013) Analysis of induced pluripotent stem cells from a BRCA1 mutant family. Stem Cell Reports 1:336-49
|
|
Foley, Samantha B; Hildenbrand, Zacariah L; Soyombo, Abigail A et al. (2013) Expression of BCR/ABL p210 from a knockin allele enhances bone marrow engraftment without inducing neoplasia. Cell Rep 5:51-60
|
|
Ross, Theodora S (2012) Grace Rock's consent. Endocr Relat Cancer 19:C29-31
|
|
Ames, Heather M; Bichakjian, Christopher K; Liu, Grace Y et al. (2011) Huntingtin-interacting protein 1: a Merkel cell carcinoma marker that interacts with c-Kit. J Invest Dermatol 131:2113-20
|
|
Oravecz-Wilson, Katherine I; Philips, Steven T; Yilmaz, Omer H et al. (2009) Persistence of leukemia-initiating cells in a conditional knockin model of an imatinib-responsive myeloproliferative disorder. Cancer Cell 16:137-48
|
|
Graves, Chiron W; Philips, Steven T; Bradley, Sarah V et al. (2008) Use of a cryptic splice site for the expression of huntingtin interacting protein 1 in select normal and neoplastic tissues. Cancer Res 68:1064-73
|
Showing the most recent 10 out of 20 publications
